Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Cohance Lifesciences Limited (NSE: COHANCE), ISIN INE03QK01018 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
COHANCE last traded at ₹443.00 (+0.23%), with a 52-week range of ₹266.70 to ₹715.00 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 57.48%, FIIs 7.71%, DIIs 18.86%, mutual funds 16.93%.
EquiSense Score (ECS): 49/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.